Our purpose
Our story
Miltenyi Biomedicine is a clinical-stage biopharmaceutical company focused on developing effective cell therapies. Our clinical programs are built on decades of expertise in cell processing, automation, and GMP manufacturing. We build on Miltenyi Biotec technologies, trusted globally by clinicians and researchers for more than 30 years, to advance the next generation of cell therapies.
Our mission
Our mission is to expand access to cell therapies for patients with difficult-to-treat indications. Delivering meaningful impact requires more than a prescription. We are committed to developing and providing cell therapies for a broad range of diseases while working to improve quality of life throughout the treatment journey.
Our current focus is on hematological cancers, with investigational CAR-T programs in development. Our goal is to increase the number of patients who can benefit from next-generation cell and gene therapies by offering more effective treatment options and reducing time to treatment.
Our values
Patients first. Every decision we make is guided by one central question: is this the right thing for patients? We are committed to improving both survival and quality of life, ensuring that patients remain at the heart of our work.
Evidence-driven. We act on facts, data, and transparency. Our programs and technologies are developed to the highest scientific standards, grounded in evidence and rigorous clinical research.
Fairness at all levels. We apply fairness in how we serve patients, work with colleagues, and build our culture. Integrity defines our operations and underpins our responsibility to patients, society, and science.